On 2025-05-06, Beam Therapeutics Inc. (BEAM) announced earnings per share of $-1.24 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-1.11.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-1.04 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-1.11 | $-1.24 |
| 2025-02-25 | 2024-12-31 | $-1.10 | $-1.09 |
| 2024-11-05 | 2024-09-30 | $-1.13 | $-1.17 |
| 2024-08-06 | 2024-06-30 | $-1.13 | $-1.11 |
| 2024-05-07 | 2024-03-31 | $-1.45 | $-1.21 |
| 2024-02-27 | 2023-12-31 | $-1.15 | $1.73 |
| 2023-11-08 | 2023-09-30 | $-1.37 | $-1.22 |
| 2023-08-08 | 2023-06-30 | $-1.38 | $-1.08 |
| 2023-05-10 | 2023-03-31 | $-1.36 | $-1.33 |
| 2023-02-28 | 2022-12-31 | $-1.32 | $-0.54 |
| 2022-11-07 | 2022-09-30 | $-1.30 | $-1.56 |
| 2022-08-09 | 2022-06-30 | $-1.08 | $-1.02 |
| 2022-05-09 | 2022-03-31 | $-1.10 | $-1.01 |
| 2022-02-28 | 2021-12-31 | $-1.02 | $-0.85 |
| 2021-11-08 | 2021-09-30 | $-0.78 | $-0.42 |
| 2021-08-10 | 2021-06-30 | $-0.58 | $-0.95 |
| 2021-05-11 | 2021-03-31 | $-0.72 | $-3.35 |
| 2021-03-15 | 2020-12-31 | $-0.70 | $-0.72 |
| 2020-11-10 | 2020-09-30 | $-0.57 | $-0.69 |
| 2020-08-12 | 2020-06-30 | $-0.56 | $-0.69 |
| 2020-05-12 | 2020-03-31 | $-0.55 | $-1.03 |